Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 14 Uveal Melanoma 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Basal Cell 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Tertiary Lymphoid Structures 1 Spinocerebellar Degenerations 1 Sarcoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Microsatellite Instability 1 Male Urogenital Diseases 1 Locally Advanced Melanoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Gastroesophageal Cancer 1

Interventions

Carboplatin 330 Pemetrexed 266 Cisplatin 234 Docetaxel 195 Paclitaxel 182 Radiotherapy 181 Erlotinib Hydrochloride 153 pembrolizumab 147 Gemcitabine 147 Bevacizumab 125 Drug Therapy 121 Radiosurgery 115 Nivolumab 112 osimertinib 92 durvalumab 88 Gefitinib 67 atezolizumab 63 Vinorelbine 63 Surgical Procedures, Operative 62 Magnetic Resonance Spectroscopy 54 anlotinib 42 Immunotherapy 42 Taxes 39 Blood Specimen Collection 39 Ipilimumab 38 130-nm albumin-bound paclitaxel 38 Specimen Handling 36 Immune Checkpoint Inhibitors 35 Radiation 34 Albumin-Bound Paclitaxel 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Non-Small-Cell Lung × relatlimab × Clear all

NCT04205552 2024-05-09

NEOpredict

University Hospital, Essen

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡